Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation

Tania Jain, Heidi E. Kosiorek, Thomas E. Grys, Shu Ting Kung, Vishal S. Shah, Jeffrey A. Betcher, James L. Slack, Jose F. Leis, Nandita Khera, Pierre Noel, Jeanne M. Palmer, Lisa Z. Sproat

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences